What is the expected growth forecast for the Virus Nucleic Acid Isolation Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Virus Nucleic Acid Isolation Kit market?

Increasing demand for molecular diagnostics and rising prevalence of infectious diseases.

What are the major challenges facing the Virus Nucleic Acid Isolation Kit market?

High cost of kits and lack of skilled professionals in emerging economies.

Which regions are leading the Virus Nucleic Acid Isolation Kit market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Virus Nucleic Acid Isolation Kit market?

Leading companies include Thermo Fisher, Roche, and Qiagen, offering high-quality isolation kits.

What future opportunities exist in the Virus Nucleic Acid Isolation Kit market?

Emerging economies and increasing adoption of molecular diagnostics offer significant growth opportunities.

How is technology impacting the Virus Nucleic Acid Isolation Kit market?

Advances in automation and nucleic acid extraction technologies are improving kit efficiency and accuracy.

What is the current regulatory landscape for the Virus Nucleic Acid Isolation Kit market?

Stringent regulations and standards, such as FDA and CE markings, govern the market and ensure kit quality.

What is the future outlook for the Virus Nucleic Acid Isolation Kit market?

The market is expected to witness significant growth due to increasing demand for molecular diagnostics and rising infectious disease prevalence.

Virus Nucleic Acid Isolation Kit - Strategic Insights: Analysis 2025 and Forecasts 2033

Virus Nucleic Acid Isolation Kit by Application (DNA Extraction, RNA Extraction), by Types (Magnetic Beads Method, Spin Column Method, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Virus Nucleic Acid Isolation Kit Market Size | CAGR 12.8 Forecast 2033

Virus Nucleic Acid Isolation Kit - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Virus Nucleic Acid Isolation Kit Market Overview

The Virus Nucleic Acid Isolation Kit market refers to the industry that provides solutions for the extraction and isolation of viral nucleic acids, which is crucial for various applications such as diagnostics, research, and vaccine development. As the Virus Nucleic Acid Isolation Kit market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by the increasing demand for molecular diagnostics and the rising prevalence of viral diseases. The industry expansion is further fueled by advancements in technology, government initiatives, and the growing need for accurate and efficient diagnostic tools.

Loading chart…

The current Virus Nucleic Acid Isolation Kit market size is driven by the growing demand for molecular diagnostics, with a growth forecast indicating a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033. The key forces shaping the industry include technological advancements in nucleic acid isolation, regulatory requirements for diagnostic kits, and changing consumer behavior towards preventative healthcare. The largest region in the market is North America, while the fastest-growing region is Asia Pacific, driven by the increasing prevalence of viral diseases and the expanding healthcare infrastructure. As the industry continues to evolve, it is essential for market players to stay informed about the latest trends, challenges, and opportunities to maintain a competitive edge.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	6.03 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbexa; Biocompare; Bio-Helix; Biotechrabbit; ELISABETH PHARMACON; Geneaid Biotech; GeneDireX; MACHEREY-NAGEL; NZYTech; Promega; Roche Diagnostics; Takara Bio; Thermo Fisher; TIANLONG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Virus Nucleic Acid Isolation Kit market is poised for significant growth, driven by factors such as increasing demand for precise and efficient diagnostic tools. The growth forecast for the Virus Nucleic Acid Isolation Kit market size is expected to be substantial, driven by the rising need for rapid and reliable nucleic acid isolation kits.

Growth Drivers2 items

Advances in molecular diagnostics and genomics are driving the adoption of Virus Nucleic Acid Isolation Kits, leading to an increase in the Virus Nucleic Acid Isolation Kit market size

The growing prevalence of infectious diseases and the need for early detection and treatment are fueling the demand for Virus Nucleic Acid Isolation Kits, contributing to a positive growth forecast

Restraints2 items

The high cost of Virus Nucleic Acid Isolation Kits and the need for specialized equipment and trained personnel may limit their adoption in resource-poor settings, affecting the overall Virus Nucleic Acid Isolation Kit market

The presence of stringent regulations and complex reimbursement policies may hinder the growth of the Virus Nucleic Acid Isolation Kit market size and impact the growth forecast

Opportunities2 items

The increasing demand for point-of-care diagnostics and the development of portable and user-friendly Virus Nucleic Acid Isolation Kits are expected to drive growth in the Virus Nucleic Acid Isolation Kit market

The growing focus on personalized medicine and the need for precise and reliable diagnostic tools are creating new opportunities for players in the Virus Nucleic Acid Isolation Kit market, leading to an increase in the Virus Nucleic Acid Isolation Kit market size

Challenges2 items

The competition in the Virus Nucleic Acid Isolation Kit market is intense, with several established players and new entrants, which may affect the growth forecast and Virus Nucleic Acid Isolation Kit market size

The need to stay updated with the latest technological advancements and regulatory requirements is a significant challenge for players in the Virus Nucleic Acid Isolation Kit market, requiring ongoing investment in research and development

Market Segmentation

Loading chart…

The Virus Nucleic Acid Isolation Kit market can be segmented based on Application, which includes various fields such as research and development, clinical diagnostics, and forensic analysis. Each of these applications contributes to the overall market size, with research and development being a significant contributor due to the increasing need for virus nucleic acid isolation in scientific studies.

The Types of Virus Nucleic Acid Isolation Kits available in the market include magnetic bead-based, silica-based, and other types. These kits are used for the isolation of viral RNA and DNA from various samples, and their demand varies based on factors such as ease of use, cost, and efficiency. Understanding the Virus Nucleic Acid Isolation Kit segmentation is crucial for manufacturers to develop targeted products and marketing strategies.

Virus Nucleic Acid Isolation Kit Segmentation Breakdown7 items

Application

DNA Extraction

RNA Extraction

Types

Magnetic Beads Method

Spin Column Method

Others

Regional Insights

Loading chart…

The Virus Nucleic Acid Isolation Kit market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and also the fastest-growing region. The key drivers for Asia Pacific include increasing adoption of nucleic acid isolation kits in research and diagnostic applications, government policies supporting the development of life science infrastructure, and investments in biotechnology research.

In North America, key drivers include established infrastructure, high ecosystem maturity, and demographics with a high demand for diagnostic services. Europe is driven by regulatory support, research collaborations, and public-private partnerships. Latin America's growth is driven by expanding healthcare infrastructure, increasing disease prevalence, and growing demand for diagnostic kits. The Middle East & Africa region is driven by government initiatives, infrastructure development, and rising healthcare expenditure.

The regional forecast indicates that the Virus Nucleic Acid Isolation Kit market will experience significant growth in the coming years, driven by increasing demand for diagnostic and research applications. Understanding the regional dynamics and key drivers is crucial for market players to develop effective strategies and capitalize on emerging opportunities.

Competitive Landscape

The Virus Nucleic Acid Isolation Kit market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Virus Nucleic Acid Isolation Kit competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships, while local companies emphasize regional expansion and cost-effective solutions.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players adopt distinct strategies to navigate the market, as outlined below:

Abbexa: regional expansion

Biocompare: premium pricing

Bio-Helix: innovation pipeline

Biotechrabbit: OEM tie-ups

ELISABETH PHARMACON: local manufacturing

Geneaid Biotech: vertical integration

Key Virus Nucleic Acid Isolation Kit Companies14 items

Abbexa

Biocompare

Bio-Helix

Biotechrabbit

ELISABETH PHARMACON

Geneaid Biotech

GeneDireX

MACHEREY-NAGEL

NZYTech

Promega

Roche Diagnostics

Takara Bio

Thermo Fisher

TIANLONG

Market Ecosystem

The Virus Nucleic Acid Isolation Kit ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where kits are manufactured and integrated; and downstream, where end users purchase and utilize the kits. Value is created and captured at each stage, with technology providers and suppliers influencing the development of kits, and end users driving demand.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — produce Virus Nucleic Acid Isolation Kits

Technology providers — develop underlying technologies

System integrators / EPCs — integrate kits into larger systems

Distributors / channel partners — facilitate kit sales and distribution

Regulators/standards bodies — establish standards and approvals

End users / buyers — purchase and utilize the kits

In the Virus Nucleic Acid Isolation Kit ecosystem, control points are largely influenced by regulators and standards bodies, as they dictate the approvals and certifications required for kit adoption. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact kit development and sales. Switching costs and partnerships also play a crucial role, as end users may face significant costs when switching between different kits or manufacturers. Furthermore, the ecosystem may differ by region, with varying regulatory requirements and market demands. A thorough value chain analysis is necessary to understand these intricacies and navigate the complex Virus Nucleic Acid Isolation Kit ecosystem.

Recent Industry Insights

The Virus Nucleic Acid Isolation Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product portfolios and expanding global reach. Notable mergers and acquisitions have also occurred, leading to increased consolidation in the market. Furthermore, several companies have launched new products and technologies, improving the efficiency and accuracy of nucleic acid isolation. Regulatory changes have also had an impact, with updated guidelines and standards for diagnostic kits. A shift in consumer and enterprise trends has been observed, with a growing demand for rapid and reliable diagnostic solutions. Additionally, funding rounds and expansions have been announced, supporting the growth of innovative companies in the sector.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Virus Nucleic Acid Isolation Kit market outlook is highly attractive, driven by increasing demand for molecular diagnostics and research applications. The competitive intensity in this market is moderate, with key players focusing on innovation and product differentiation. The long-term outlook for this market is positive, with growing adoption of nucleic acid isolation kits in various end-use industries.

The innovation landscape is rapidly evolving, with advancements in technologies such as magnetic bead-based isolation and automated nucleic acid extraction. However, the demand-supply balance is a key risk factor, as fluctuations in raw material availability and supply chain disruptions can impact market growth. Overall, the Virus Nucleic Acid Isolation Kit market is expected to experience significant growth, driven by increasing demand for high-quality nucleic acid isolation kits.

12 items

1. Executive Summary

2. Virus Nucleic Acid Isolation Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Virus Nucleic Acid Isolation Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Virus Nucleic Acid Isolation Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Virus Nucleic Acid Isolation Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Virus Nucleic Acid Isolation Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Virus Nucleic Acid Isolation Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Virus Nucleic Acid Isolation Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Virus Nucleic Acid Isolation Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Virus Nucleic Acid Isolation Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Virus Nucleic Acid Isolation Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Virus Nucleic Acid Isolation Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Virus Nucleic Acid Isolation Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Virus Nucleic Acid Isolation Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Virus Nucleic Acid Isolation Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Virus Nucleic Acid Isolation Kit Market Competition by Key Manufacturers

9.1. Global Virus Nucleic Acid Isolation Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Virus Nucleic Acid Isolation Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbexa

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Biocompare

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Bio-Helix

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Biotechrabbit

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ELISABETH PHARMACON

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Geneaid Biotech

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. GeneDireX

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. MACHEREY-NAGEL

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. NZYTech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Promega

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Roche Diagnostics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Takara Bio

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Thermo Fisher

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. TIANLONG

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Virus Nucleic Acid Isolation Kit Market

Figure 4: Global Virus Nucleic Acid Isolation Kit Market: Drivers

Figure 5: Global Virus Nucleic Acid Isolation Kit Market: Challenges

Figure 6: Global Virus Nucleic Acid Isolation Kit Market: Trends

Figure 7: Global Virus Nucleic Acid Isolation Kit Market: Opportunity

Figure 8: Global Virus Nucleic Acid Isolation Kit Market: Restraint

Figure 9: Global Virus Nucleic Acid Isolation Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Virus Nucleic Acid Isolation Kit Market Value (USD Million) By Region

Figure 19: Global Virus Nucleic Acid Isolation Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Virus Nucleic Acid Isolation Kit Market Value (USD Million) By Region

Figure 27: Global Virus Nucleic Acid Isolation Kit Market Share (%) By: Regions (2032)

Figure 28: Global Virus Nucleic Acid Isolation Kit Market Volume (K) By Region

Figure 29: Global Virus Nucleic Acid Isolation Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Virus Nucleic Acid Isolation Kit Market Value (USD Million) By Region

Figure 37: Global Virus Nucleic Acid Isolation Kit Market Share (%) By: Regions (2032)

Figure 38: Global Virus Nucleic Acid Isolation Kit Market Volume (K) By Region

Figure 39: Global Virus Nucleic Acid Isolation Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Virus Nucleic Acid Isolation Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Virus Nucleic Acid Isolation Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Virus Nucleic Acid Isolation Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Virus Nucleic Acid Isolation Kit Market Value (USD Million) By Region

Table 14: Global Virus Nucleic Acid Isolation Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Virus Nucleic Acid Isolation Kit Market Volume (K) By Region

Table 31: Global Virus Nucleic Acid Isolation Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Virus Nucleic Acid Isolation Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Virus Nucleic Acid Isolation Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Virus Nucleic Acid Isolation Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbexa Basic Information And Sales Area

Table 52: Abbexa. Products Portfolio

Table 53: Biocompare Basic Information And Sales Area

Table 54: Biocompare. Products Portfolio

Table 55: Bio-Helix Basic Information And Sales Area

Table 56: Bio-Helix. Products Portfolio

Table 57: Biotechrabbit Basic Information And Sales Area

Table 58: Biotechrabbit. Products Portfolio

Table 59: ELISABETH PHARMACON Basic Information And Sales Area

Table 60: ELISABETH PHARMACON. Products Portfolio

Table 61: Geneaid Biotech Basic Information And Sales Area

Table 62: Geneaid Biotech. Products Portfolio

Table 63: GeneDireX Basic Information And Sales Area

Table 64: GeneDireX. Products Portfolio

Table 65: MACHEREY-NAGEL Basic Information And Sales Area

Table 66: MACHEREY-NAGEL. Products Portfolio

Table 67: NZYTech Basic Information And Sales Area

Table 68: NZYTech. Products Portfolio

Table 69: Promega Basic Information And Sales Area

Table 70: Promega. Products Portfolio

Table 71: Roche Diagnostics Basic Information And Sales Area

Table 72: Roche Diagnostics. Products Portfolio

Table 73: Takara Bio Basic Information And Sales Area

Table 74: Takara Bio. Products Portfolio

Table 75: Thermo Fisher Basic Information And Sales Area

Table 76: Thermo Fisher. Products Portfolio

Table 77: TIANLONG Basic Information And Sales Area

Table 78: TIANLONG. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Virus Nucleic Acid Isolation Kit Market Value (USD Million) By Region

Table 88: Global Virus Nucleic Acid Isolation Kit Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Virus Nucleic Acid Isolation Kit Market Volume (K) By Region

Table 105: Global Virus Nucleic Acid Isolation Kit Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Virus Nucleic Acid Isolation Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	6.03 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbexa; Biocompare; Bio-Helix; Biotechrabbit; ELISABETH PHARMACON; Geneaid Biotech; GeneDireX; MACHEREY-NAGEL; NZYTech; Promega; Roche Diagnostics; Takara Bio; Thermo Fisher; TIANLONG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options